We review here some recent data about glucose-6-phosphate dehydrogenas
e (G6PD), the first and key regulatory enzyme of the pentose phosphate
pathway. New evidence has been presented to suggest that malaria is a
selective agent for G6PD deficiency, which is the most common enzymop
athy in man, and that G6PD deficiency, generally considered to be a mi
ld and benign condition, is significantly disadvantageous in certain e
nvironmental conditions. At the molecular level, the enzyme structure
has recently been elucidated and mechanisms regulating G6PD gene expre
ssion have been determined. A G6PD knock-out mutation introduced in mo
use cells makes them exquisitely sensitive to oxidative stress, indica
ting that this ubiquitous metabolic enzyme has a major role in the def
ence against oxidative stress, even in eukaryotic nucleated cells, whi
ch have several alternative routes for providing the same protection.
Because of the high prevalence of G6PD deficiency in many populations,
it is expected that these findings will prompt further studies to asc
ertain the putative role of G6PD deficiency in conditions such as carc
inogenesis and ageing.